Chemical Biology for Drug Discovery

This symposium represents the first collaboration between the RSC Biological and Medicinal Chemistry Sector and Oxford University's Structural Genomics Consortium.  It aims to bring together chemists and biologists to explore how the interdisciplinary field of Chemical Biology is enhancing our understanding of the molecular mechanisms of disease.

Topics will include discovery of chemical probes, protein-protein interactions, chemical modification of biological molecules, pathway deconvolution, chemical genetics and association of molecular targets with disease.  These will be accompanied by perspectives on the growing trend of academic-industrial collaborations impacting chemical biology for drug discovery. 

The meeting will include a Poster Session, details of submission requirements are to be found in the Final Circular.

Confirmed speakers include

Prof Andrew Hamilton, Vice-Chancellor elect, Oxford University
Dr Tony Wood, Pfizer UK
Dr Corey Nislow, University of Toronto
Prof Andrew Hopkins, University of Dundee
Prof Georg Terstappen, Siena Biotech
Prof Ben Cravatt, Scripps
Prof Sheng Ding, Scripps
Prof Roger Griffin, University of Newcastle
Prof Malcolm Stevens, University of Nottingham
Prof Andrew Hattersley, University of Exeter
Prof Herbert Waldmann, Max Planck Institute, Dortmund
Dr Chun-wa Chung, GlaxoSmithKline
Prof Barry Potter, University of Bath
Prof Stuart Conway, Oxford University
Dr Julie Frearson, Dundee University

A Conference Dinner and overnight accommodation will be available at St Anne's College.
 

FINAL CIRCULAR

Please click here to open a pdf of the Final Circular and Application Form.   Attendance will be limited to 150 delegates so early application is advised.  Full details are included in the circular.